NCT02848066View on ClinicalTrials.gov

Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker

CompletedOBSERVATIONAL
Enrollment

353

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2017

Conditions
Gastric Cancer
Interventions
PROCEDURE

Blood sample(10cc) collection

In both groups, serum haptoglobins to be collected and analyzed

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02848066 - Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker | Biotech Hunter | Biotech Hunter